Raúl Jesús A. B.
- Country
- Spain
- Department
- Gastroenterology and Hepatology
Research Overview
- Evaluation of Long-Term Safety and Tolerability of Seladelpar in Patients with Primary Biliary Cholangitis
- Efficacy and Safety Evaluation of Pemafibrate and Tofogliflozin Combination in Noncirrhotic NASH with Liver Fibrosis: A Phase 2 Randomized, Double-Blind Study
- Efficacy and Safety of Subcutaneous Amlitelimab in Adults with Non-Responsive Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 2a/b Study
Data & Insights
Has run more than one trial at 27 of 145 partner sites.
Specializations
Liver Disease Management
The investigator specializes in treating various forms of chronic liver conditions, with particular emphasis on nonalcoholic steatohepatitis (NASH) and liver fibrosis. Their research encompasses innovative therapeutic approaches for liver disease progression.
- Nonalcoholic Fatty Liver Disease
- Primary Biliary Cholangitis
- Hepatic Encephalopathy
Genetic and Metabolic Disorders
The investigator focuses on treating genetic liver disorders, particularly Alpha-1 Antitrypsin Deficiency-associated liver disease. Their work involves evaluating novel therapeutic approaches for managing these inherited conditions.
- Alpha-1 Antitrypsin Deficiency
- Metabolic Liver Diseases
- Genetic Liver Disorders
Viral Hepatitis and Gastrointestinal Disorders
The investigator conducts research in treating chronic viral hepatitis and various gastrointestinal conditions. Their expertise extends to celiac disease management and innovative therapeutic approaches.
- Chronic Hepatitis B
- Chronic Hepatitis C
- Non-responsive Celiac Disease
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.